Approximately 50% of prostate cancer patients receiving radiotherapy develop erectile
dysfunction within 3–5 years. The precise role of radiation-induced neurogenic injury post …

Purpose/Objectives Radiation-induced erectile-dysfunction (RiED) is one of the most
common side effects of radiation therapy (RT) and significantly reduces the quality of life …

Abstract Objectives Prostate cancer (PCa) treatment with radiation therapy (RT) has an
excellent cure rate. However, Radiation-induced Erectile Dysfunction (RiED) is a common …

Results ICP measurements were conducted in order to analyze nerve-mediated penile
erection. There was a significant (P< 0.001) reduction of ICP/MAP ratio in RT rats compared …

Background Erectile dysfunction (ED) is common following radiation therapy (RT) for
prostate cancer. Although the cause of RT-induced ED is unknown, damage to both the …

Introduction The mechanisms of radiation‐induced erectile dysfunction (ED) are unclear, as
clinical studies are limited, and previous animal models were based on wide‐field …

Prostate cancer is one of the most prevalent cancers and the second leading cause of
cancer-related deaths in men in the United States. A large number of patients undergo …

Purpose/Objectives Erectile dysfunction is common after radiation therapy for prostate
cancer; yet, the etiopathology of radiation-induced erectile dysfunction (RI-ED) remains …

Following prostate cancer treatment, many men will experience urogenital side effects
including erectile dysfunction (ED), a condition significantly affecting survivor quality of life …

Results RT significantly impaired the vasodilatory response to hydralazine which was
protected by VRA (change in IPA diameter+ 28% for sham/saline,-7.4% for RT/saline,+ 24 …